STUDY TO KNOW THE INCIDENCE OF INSULIN RESISTANCE IN POLYCYSTIC OVARIAN SYNDROME PATIENTS

被引:0
作者
Pirzada, Risham Fatima [1 ]
Khan, Nadeem [2 ]
Afzal, Ayisha [1 ]
机构
[1] Univ Coll Med & Dent, Lahore, Pakistan
[2] Multan Med & Dent Coll, Multan, Pakistan
来源
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2018年 / 5卷 / 08期
关键词
Polycystic ovarian syndrome; Insulin resistance; homeostatic; model evaluation;
D O I
10.5281/zenodo.1403817
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: To determine the incidence of insulin resistance (IR) in polycystic ovarian syndrome patients with simple insulin resistance indices and to know the relation of PCOS clinical manifestations with insulin resistance indices. Study Design: A cross-sectional study. Place and Duration: In the Endocrinology Department of Services hospital, From December 2016 to December 2017 for duration of one year. Methodology:. A hundred patients who met the Rotterdam 2003 diagnostic criteria for polycystic ovarian syndrome were selected for the study. Descriptive statistics was recorded with standard deviation and frequency. Using fasting insulin levels (> 10 IU / ml) Insulin resistance (IR) was calculated, fasting glucose /insulin ratio (> 4.6). The different indirect IR signals were calculated as McAuley (< 5.8), QUICKI (< 0.357) and HOMA-IR (> 2.7). Findings: HOMA-IR, QUICKI and McAuley values were 65%, 88% and 51.2% in patients with PCOS, respectively. Patients with Blood sugar fasting levels (> 10 uu / ml) were 76.02%. With hirsutism, infertility and obesity the most common presentation was Menstrual irregularities. There was a strong relation between various irregularities, insulin resistance and hyperinsulinemia. Conclusion: High-frequency insulin resistance and hyperinsulinemia were seen in patients with polycystic ovariansyndrome. With insulin resistance indices great numbers of clinical manifestations are related.
引用
收藏
页码:7970 / 7974
页数:5
相关论文
共 15 条
[1]  
Barber T. M., 2018, PEDIAT OBESITY, P629
[2]  
Giandalia Annalisa, 2018, J CLIN TRANSLATIONAL
[3]  
Gyftaki Reveka, 2018, 20 EUR C END, V56
[4]  
Hassani Fatemeh, 2019, CELL, V1, P21
[5]   Morning blood pressure surge and its relation to insulin resistance in patients of reproductive age with polycystic ovary syndrome [J].
Kadi, Hasan ;
Avci, Eyup ;
Usta, Akin ;
Demirtas, Abdullah Orhan .
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2018, 16
[6]   Research trends of flipped classroom studies for medical courses: a review of journal publications from 2008 to 2017 based on the technology-enhanced learning model [J].
Lin, Hui-Chen ;
Hwang, Gwo-Jen .
INTERACTIVE LEARNING ENVIRONMENTS, 2019, 27 (08) :1011-1027
[7]  
Markou A., 2018, 20 EUR C END, V56
[8]   Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance [J].
Morishita, Miyuki ;
Endo, Toshiaki ;
Baba, Tsuyoshi ;
Kuno, Yoshika ;
Ikeda, Keiko ;
Kiya, Tamotsu ;
Honnma, Hiroyuki ;
Saito, Tsuyoshi .
JOURNAL OF OVARIAN RESEARCH, 2018, 11
[9]   Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance [J].
Naderpoor, Negar ;
Shorakae, Soulmaz ;
Abell, Sally K. ;
Mousa, Aya ;
Joham, Anju E. ;
Moran, Lisa J. ;
Stepto, Nigel K. ;
Spritzer, Poli Mara ;
Teede, Helena J. ;
de Courten, Barbora .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 177 :209-215
[10]  
Pascual-Corrales Eider, 2018, 20 EUR C END, V56